Express News | Aclaris Therapeutics Inc -Files Prospectus for Offer, Resale by Selling Stockholders of up to 35.6 Mln Shares of Common Stock

BreakingsDec 20 05:34

Jefferies Maintains Aclaris Therapeutics(ACRS.US) With Buy Rating, Maintains Target Price $7

Futu NewsDec 18 23:33 · Ratings

Aclaris Therapeutics: Promising Pipeline and Strong Financial Outlook Drive Buy Rating

TipRanksDec 18 22:35 · Ratings

Stifel Maintains Aclaris Therapeutics(ACRS.US) With Hold Rating, Raises Target Price to $5

Futu NewsDec 17 10:32 · Ratings

Stifel Nicolaus Remains a Hold on Aclaris Therapeutics (ACRS)

TipRanksDec 17 10:05 · Ratings

Sino biopharm (01177.HK) has reached a global cooperation agreement with博奥信 and aclaris therapeutics.

On December 5th, Gelonghui reported that sino biopharm (01177.HK) announced that the group has reached a global cooperation agreement with Aclaris Therapeutics, Inc. concerning their jointly developed TSLP monoclonal antibody "BSI-045B (TQC2731)" with Boaoxin Biotechnology (Nanjing) Co., Ltd. ("Boaoxin").

Gelonghui FinanceDec 5 16:32